monitor B1 status
The pill is the right choice for some patients and not for others
investigational drugs 32 (1), 516
Red flags for unsafe peptides Avoid peptides with: High rates of serious side effects Unknown long-term consequences Hormonal disruption risks Organ growth potential Insulin resistance development Difficult-to-manage complications Warning signs: Peptide is "research only" with minimal human data Requires aggressive cycling to avoid tolerance Causes permanent changes (bone/organ growth) Difficult to source safely (suggests regulatory concerns) Risk vs reward assessment Safest peptides: Healing peptides (BPC-157, TB-500) - massive reward, minimal risk Moderate GH peptides (CJC-1295, Ipamorelin) - good reward, low risk Moderate safety: GHRP-6 - good reward, moderate risk (appetite, prolactin) Hexarelin - excellent reward, higher risk (desensitization, cortisol) Higher risk: IGF-1 LR3 - excellent reward, significant risk (hypoglycemia, organ effects) High-dose GH peptides - potential thyroid, insulin issues See our best peptides for muscle growth for comprehensive muscle-building options and peptides vs steroids comparison to understand relative safety
The third driver, estrogen dependence, is also potentially influenced by GLP-1 medications, through a different mechanism entirely
Peptide suppliers don't advertise this openly because the economics favour frequent reordering
